Pfizer is one of several drugmakers working to develop an alternative to injectable weight loss drugs. Still, it’s far behind rivals like Eli Lilly and Novo Nordisk, who already lead the market with ...
With the world continuing to pack on pounds, there is an urgent need for effective weight management in an increasingly health-conscious world. According to an industry report, the global weight-loss ...
JPMorgan has reset the valuation for Viking Therapeutics Inc. (NASDAQ:VKTX) and Structure Therapeutics Inc. (NASDAQ:GPCR). Analyst Hardik Parikh cites several reasons for recovery, including pathways ...
Shares of Viking Therapeutics (VKTX) are up 13% to $25.17 in early trading while Structure Therapeutics (GPCR) is up 7% to 17.02. Discover outperforming stocks and invest smarter with Top Smart Score ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results